MUFACE and the General Council of Pharmacists held on 26 January a protocolary act concerning the signing of the Convention formalising the concert to lay down the conditions for the execution of the pharmaceutical benefit of the Mutuality through the pharmacy offices.
Both entities continue to work on the implementation of the agreed electronic prescription throughout the national territory.
This collaboration instrument, published in the BOE of 7 January 2023, sets out the conditions under which pharmacies collaborate with MUFACE in dispensing to the mutual group of medicines, master preparations and formulas, effects and accessories, antiallergic and bacterial vaccines, included in the pharmaceutical provision of the National Health System of which MUFACE is part.
Link the document in the BOE.